Randomized Clinical Trial
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Dec 16, 2022; 14(12): 777-788
Published online Dec 16, 2022. doi: 10.4253/wjge.v14.i12.777
Table 5 Patient-reported outcomes for the intention-to-treat analysis (n, %)
Patient-reported outcomes – Likert scale
SNC (n = 154)
HFMG (n = 138)
P value
(1 = Very uncomfortable or unbearable, 5 = Very comfortable or not at all)
Response rate115, 74.7%102, 73.9%0.882
Comfort level ≤ 24, 3.5%5, 4.9%0.6
Abdominal pain ≤ 23, 2.6%0, 0.0%0.1
Bloating ≤ 21, 0.9%1, 1.0%0.932
Mouth dryness ≤ 22, 1.7%1, 1.0%0.633
Mouth pain ≤ 22, 1.7%1, 1.0%0.633
Headache ≤ 21, 0.9%1, 1.0%0.932